AQP1 and glaucoma: However, oxygen-induced retinal microvessel proliferation was not affected by AQP1 deletion in a neonatal mouse model of oxygen-deprivation retinopathy, which suggested that AQP1 inhibitors may be used to treat ocular disorders such as glaucoma because retinal vessel proliferation was AQP1 independent [48].